Dynocardia, Inc. — Form D/A

Dynocardia, Inc. of NEWTON CENTER, MA, a company, filed a Form D amendment with the SEC on 2025-03-20. The offering totals $5.3M, of which $3.7M was reported sold. Industry: Other Health Care.

Offering

Filed: 2025-03-20
Form: D/A
Accession: 0001776173-25-000002
Industry: Other Health Care
Exemptions: 06b
Total offering: $5.3M
Amount sold: $3.7M
Remaining: $1.6M
Investors: 35
Date of first sale: 2023-03-24
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-477784

Issuer

Name: Dynocardia, Inc.
CIK: 0001776173
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2018
Address: 1188 CENTER STREET STE 2, NEWTON CENTER, MA, 02459-1556
Phone: 617-639-5569

Officers, directors & promoters (2)

Name	Role	Location
Mohan Thanikachalam	Director	NEWTON CENTRE, MA
Mohan Thanikachalam	Executive Officer	NEWTON CENTRE, MA

Other filings by this issuer (11)

Filed	Form	Offering	Sold
2025-12-12	D/A	$2.0M	$1.2M
2025-12-12	D/A	$6.0M	$4.8M
2025-03-14	D	$2.0M	$675K
2025-01-06	D/A	$6.0M	$3.7M
2024-04-04	D/A	$6.0M	$1.5M
2023-04-03	D	$6.0M	$1.5M
2021-01-21	D/A	$2.5M	$2.0M
2020-10-30	D/A	$500K	$490K
2020-10-30	D/A	$2.0M	$1.8M
2020-02-14	D	$2.0M	$350K
2019-05-13	D	$500K	$340K

More